Results 141 to 150 of about 72,150 (302)

Low Dose of IL‐2 Application for Graft‐Versus‐Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation

MedComm, Volume 7, Issue 2, February 2026.
Early low‐dose IL‐2 administration after haploidentical HSCT promotes the reconstitution of NK cells and regulatory T cells (Tregs), enhances their activation (CD122+, DNAM‐1+, NKG2D+, CD62L+), and increases plasma cytokines (IFN‐γ, TNF‐α, IL‐10, IL‐2).
Zheng‐Li Xu, Meng Lv, Xing‐Xing Yu, Yi‐Yang Ding, Ting‐Ting Han, Hai‐Xia Fu, Yuan‐Yuan Zhang, Xiao‐Dong Mo, Yu‐Qian Sun, Lan‐Ping Xu, Xiao‐Hui Zhang, Yu Wang, Xiao‐Jun Huang, Xiang‐Yu Zhao   +13 more
wiley   +1 more source

Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in Sweden

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Background The European ALLTogether protocol for childhood acute lymphoblastic leukemia, initiated in Sweden 2019, introduced earlier asparaginase during induction, dexamethasone instead of prednisone for all patients, and omitted anthracyclines from low‐risk induction to reduce treatment‐related toxicity.
Johannes Fermér, Hannah van Bunningen, Otto Zhou, Jonas Abrahamsson, Magnus Borssen, Isabella Donnér, Mats Heyman, Anna Sällfors Holmqvist, Anders Valind, Hartmut Vogt, Susanna Ranta, Arja Harila   +11 more
wiley   +1 more source

Case report: Dysphonia associated with high-dose cytarabine therapy [PDF]

Ling Ma, Nicole Huang, Haixi Zhang, Jia Liu, Z. Zhang   +4 more
openalex   +1 more source

Cytarabine-Mitoxantrone Regimen [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Clinical presentation and management of repetitive circling behaviour in a working cocker spaniel secondary to meningoencephalomyelitis of unknown aetiology

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 3‐year‐old, entire, male cocker spaniel presented for behavioural assessment following a 2.5‐year history of compulsive circling to the right‐hand side. It was previously diagnosed with meningomyelitis of unknown aetiology, following an acute onset of blindness in the left eye and decreased postural reactions.
Emma Gatehouse, Vera Pisco
wiley   +1 more source

Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes

, 2009
Gautam Borthakur, Xuelin Huang, Hagop M. Kantarjian, Stefan Faderl, Farhad Ravandi, Alessandra Ferrajoli, Ritva Torma, Gail Morris, Donald A. Berry, Jean‐Pierre J. Issa   +9 more
openalex   +1 more source

TRPS1::PLAG1 Fusion in a Primary Cutaneous Myoepithelial Carcinoma: A Case Report and Literature Review

Journal of Cutaneous Pathology, Volume 53, Issue 2, Page 169-174, February 2026.
ABSTRACT Myoepithelial neoplasms are rare tumors that are found in the salivary glands, the breast, soft tissue, and skin. Myoepithelial carcinomas typically have a poor prognosis with a high rate of local recurrence and metastasis in the cutaneous setting.
Timber Gillis, Jenika Howell, Fatemeh Jafarian   +2 more
wiley   +1 more source

The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms’ tumor gene 1 (WT1) protein

, 2015
Giorgia Montano, Tove Ullmark, Helena Jernmark-Nilsson, Gaetano Sodaro, Kristina Drott, Paola Costanzo, Karina Vidovic, Urban Gullberg   +7 more
openalex   +2 more sources

Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients [PDF]

, 2017
Maria Ilaria Del Principe
openalex   +1 more source

Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents

European Journal of Haematology, Volume 116, Issue 2, Page 160-168, February 2026.
ABSTRACT Acute myeloid leukemia (AML) in elderly patients presents a major therapeutic challenge, as many are deemed unfit for intensive chemotherapy due to age, comorbidities, or frailty. Venetoclax in combination with hypomethylating agents (HMA) has emerged as a standard‐of‐care for this population, yet outcomes remain heterogeneous and predictive ...
Ernesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, Andrea Corsonello, Santino Caserta, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Nicola Amodio, Fortunato Morabito, Massimo Gentile   +11 more
wiley   +1 more source